Trastuzumab Completed Phase 3 Trials for HER2/Neu Over-expressing Locally Advanced Breast Cancer / Metastatic Breast Cancer (MBC) Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT00567190A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
NCT01007942Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
NCT02144012A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer